Boston-based startup LogicFlo AI, an artificial intelligence platform building purpose-built agents for life sciences, today announced it has raised $2.7 million in seed funding led by Lightspeed to scale up its agentic AI service for the pharmaceutical, biotechnology and medical technology industries.
Life sciences underpin the development of technologies, drugs and therapies for much of what innovates medical science, which is built on the back of research. The process is highly regulated and requires significant human collaboration at every step because medical technologies directly affect human lives once deployed.
AI agents are a specialized type of artificial intelligence that go beyond standard copilots and assistants, which respond only when called upon. Agents can work toward goals with very little human oversight, carrying on tasks autonomously. They can also check in with human counterparts as they work alongside them as they collect information, produce content and act as collaborators.
“While the rest of the world is focused on automation instead of people, we are building automation for people,” said co-founder and Chief Executive Udith Vaidyanathan. “LogicFlo puts experts firmly at the center. The goal is to let the brightest people in life sciences do what only they can do — drive medical science forward and help elevate the standard of care. ”
LogicFlo’s AI agents can support functions across the entire life sciences field of work including researching literature based on medical applications; medical communication and information response generation with journal articles, commercial content creation with compliant materials; regulatory authoring for safety narratives; and quality and compliance documentation such as standard operating procedures and deviation reports.
The company aims to provide a platform for workers in the life sciences industry using its AI agents to enhance their work, allowing them to complete drafts more quickly and accurately. For example, these agents can efficiently gather research for regulatory compliance reviews, significantly reducing the time required for manual work.
According to the company, medical writing tasks that once took weeks can now be accomplished in just minutes, resulting in up to a 2,000-fold reduction in the time needed to produce a first draft. In some cases, response times for medical information inquiries have decreased from weeks to days.
“Traditional automation has failed life sciences because it’s too rigid, too brittle, and too out of touch with how people actually work,” said co-founder Arun Ramakrishnan. “Our agents are different. They’re intelligent, composable, production-ready and they understand the nuance of scientific work.”
The company said every agent operates as a fully auditable, human-in-the-loop system. Agents are fully aware of standard operating procedures and best practices by adapting to the organizational culture and structure. They also train to specific templates, workflows and compliance requirements.
They’re designed to collaborate as teams, break down work into subtasks and validate outputs. That means that if they run into a condition they cannot resolve, they will escalate it to a human worker.
“We are at a once-in-a-generation inflection point,” added Vaidyanathan. “For the first time, AI agents have reached a level of capability and control that makes meaningful productivity unlocks in regulated scientific work not only possible but inevitable.”
LogicFlo said with the new funding it intends to expand its agent library, deepen integrations with the likes of global life sciences cloud provider Veeva Systems Inc. and biopharmaceutical development consulting company IQVIA Inc., and hire new talent to meet the rising demand in the sector.
“If we can give scientific experts a platform that moves at their speed, they’ll move science forward faster,” said Vaidyanathan.
Image: News/Microsoft Designer
Support our open free content by sharing and engaging with our content and community.
Join theCUBE Alumni Trust Network
Where Technology Leaders Connect, Share Intelligence & Create Opportunities
11.4k+
CUBE Alumni Network
C-level and Technical
Domain Experts
Connect with 11,413+ industry leaders from our network of tech and business leaders forming a unique trusted network effect.
News Media is a recognized leader in digital media innovation serving innovative audiences and brands, bringing together cutting-edge technology, influential content, strategic insights and real-time audience engagement. As the parent company of News, theCUBE Network, theCUBE Research, CUBE365, theCUBE AI and theCUBE SuperStudios — such as those established in Silicon Valley and the New York Stock Exchange (NYSE) — News Media operates at the intersection of media, technology, and AI. .
Founded by tech visionaries John Furrier and Dave Vellante, News Media has built a powerful ecosystem of industry-leading digital media brands, with a reach of 15+ million elite tech professionals. The company’s new, proprietary theCUBE AI Video cloud is breaking ground in audience interaction, leveraging theCUBEai.com neural network to help technology companies make data-driven decisions and stay at the forefront of industry conversations.
